Key result
Higher Time in Range (TIR) obtained from blood glucose monitoring was associated with a lower risk of cognitive impairment in patients with type 2 diabetes.
Why the study?
To investigate the association of blood glucose monitoring-derived time in range with cognitive impairment in inpatients with type 2 diabetes mellitus, and explore whether a time in range goal > 70% protects cognitive function.
Is Time in Range (TIR) associated with cognitive impairment in inpatients with Type 2 Diabetes Mellitus?
Cross-Sectional (n=274)
No
Is Time in Range (TIR) associated with cognitive impairment in inpatients with Type 2 Diabetes Mellitus?
This is the authors' abstract. We don't add key points for this paper.
OBJECTIVE This study investigated the association of Time In Range (TIR) obtained from Blood Glucose Monitoring (BGM) with Cognitive Impairment (CI) inpatients with Type 2 Diabetes Mellitus (T2DM) and further explored whether a TIR goal for T2DM in adults with > 70% possess a protective effect on cognitive function. RESEARCH DESIGN AND METHODS A total of 274 inpatients with T2DM aged 40–64 years, who underwent seven-point BGM (120 mins pre and post meals and at bedtime) were recruited in this cross-sectional study. TIR was defined as the percentage of blood glucose within the target range of 3.9-10.0mmol/L. Subjects were divided into Normal Cognitive Function (NCF) (n = 160) and CI (n = 114) groups according to the results of the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE). The association of TIR and other glycemic metrics, calculated from seven-point BGM data, with cognitive dysfunction was analyzed. RESULTS The prevalence of CI was 41.6% in patients with T2DM (median age 58 years). TIR was lower in CI group than in NCF group (28.6% vs. 42.9%, P = 0.004). The prevalence of CI decreased with ascending tertiles of TIR (p for trend < 0.05). Binary logistic regression analysis showed a significant association between TIR and CI (odds ratio [OR] = 0.84, p < 0.001) after adjusting for confounders (age, education, marital status, age at Diabetes Mellitus (DM) onset, cerebrovascular disease). Further adjustment of Standard Deviation (SD)(OR = 0.84, p = 0.001) or Coefficient of Variation (CV)(OR = 0.83, p < 0.001), TIR was still associated with CI. While a TIR goal of > 70% probably possessed independent protective effect on cognitive function (OR = 0.25, p = 0.001) after controlling for confounders above. CONCLUSIONS TIR obtained from BGM was related to CI in T2DM patients and a TIR goal of > 70% probably possessed a protective effect on cognitive function for T2DM adults.
Answers are grounded in this paper and cite their sources.
Higher Time in Range (TIR) from blood glucose monitoring, particularly >70%, is associated with a lower risk of cognitive impairment in inpatients with Type 2 Diabetes.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) conducted a cross-sectional in Type 2 Diabetes Mellitus (n=274). Time in Range (TIR) vs. Lower Time in Range was evaluated on Cognitive Impairment (CI) (OR 0.84, 95% CI 0.76-0.92, p=<0.001). Higher Time in Range (TIR) obtained from blood glucose monitoring was associated with a lower risk of cognitive impairment in patients with type 2 diabetes.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: